| Literature DB >> 35397539 |
Terese Sara Høj Jørgensen1,2, Heather Allore3,4, Miriam R Elman5, Corey Nagel6,7, Ana R Quiñones8.
Abstract
BACKGROUND: Non-Hispanic (NH) Black older adults experience substantially higher rates of potentially avoidable hospitalization compared to NH White older adults. This study explores the top three chronic conditions preceding hospitalization and potentially avoidable hospitalization among NH White and NH Black Medicare beneficiaries in the United States.Entities:
Keywords: Chronic conditions; Machine learning methods; Potentially avoidable hospitalizations; Race/ethnicity
Mesh:
Year: 2022 PMID: 35397539 PMCID: PMC8994911 DOI: 10.1186/s12913-022-07849-y
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Characteristics of respondents by race and hospitalization status
| Non-Hispanic White ( | Non-Hispanic Black ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Characteristics | Hospitalization ( | No Hospitalization ( | Hospitalization ( | No Hospitalization ( | ||||
| Age (years), mean (SD) | 80.0 | (7.5) | 78.1 | (7.2) | 78.5 | (7.5) | 76.6 | (6.7) |
| Female, n (%) | 544 | (55.6) | 2083 | (60.5) | 83 | (58.5) | 286 | (66.4) |
| Wealth (USDa), median (IQR) | 22.4 | (6.9, 61.0) | 31.9 | (11.4, 78.1) | 3.9 | (0.1, 13.2) | 6.5 | (0.6, 18.9) |
| Education (years), median (IQR) | 12.0 | (12.0, 15.0) | 12.0 | (12.0, 16.0) | 12.0 | (9.0, 12.0) | 12.0 | (10.0, 14.0) |
| Chronic Conditions, n (%)b | ||||||||
| Hypertension | 935 | (95.6) | 2848 | (82.7) | 141 | (99.3) | 393 | (91.2) |
| Hyperlipidemia | 887 | (90.7) | 2820 | (81.9) | 128 | (90.1) | 342 | (79.4) |
| Anemia | 816 | (83.4) | 1895 | (55.1) | 130 | (91.5) | 312 | (72.4) |
| Rheumatoid arthritis/osteoarthritis | 796 | (81.4) | 2154 | (62.6) | 105 | (73.9) | 276 | (64.0) |
| Ischemic heart disease | 756 | (77.3) | 1763 | (51.2) | 119 | (83.8) | 239 | (55.5) |
| Heart failure | 557 | (57.0) | 854 | (24.8) | 98 | (69.0) | 151 | (35.0) |
| Chronic kidney disease | 521 | (53.3) | 835 | (24.3) | 94 | (66.2) | 163 | (37.8) |
| Diabetes | 468 | (47.9) | 1164 | (33.8) | 98 | (69.0) | 230 | (53.4) |
| Depression | 503 | (51.4) | 1018 | (29.6) | 58 | (40.8) | 121 | (28.1) |
| COPD | 458 | (46.8) | 857 | (24.9) | 70 | (49.3) | 87 | (20.2) |
| Fibromyalgia/Chronic Pain/Fatigue | 394 | (40.3) | 838 | (24.3) | 46 | (32.4) | 91 | (21.1) |
| Atrial fibrillation | 384 | (39.3) | 573 | (16.6) | 33 | (23.2) | 41 | (9.5) |
| Acquired hypothyroidism | 359 | (36.7) | 1057 | (30.7) | 44 | (31.0) | 76 | (17.6) |
| Alzheimer’s disease/senile dementia | 325 | (33.2) | 514 | (14.9) | 64 | (45.1) | 77 | (17.9) |
| Stroke/transient ischemic attack | 323 | (33.0) | 548 | (15.9) | 56 | (39.4) | 80 | (18.6) |
| Anxiety disorders | 333 | (34.0) | 656 | (19.1) | 30 | (21.1) | 63 | (14.6) |
| Osteoporosis | 318 | (32.5) | 885 | (25.7) | 38 | (26.8) | 77 | (17.9) |
| Cancer | 303 | (31.0) | 656 | (19.1) | 39 | (27.5) | 94 | (21.8) |
| Obesity | 287 | (29.3) | 521 | (15.1) | 51 | (35.9) | 89 | (20.6) |
| Asthma | 226 | (23.1) | 402 | (11.7) | 36 | (25.4) | 69 | (16.0) |
| Pressure and chronic ulcers | 219 | (22.4) | 247 | (7.2) | 30 | (21.1) | 49 | (11.4) |
| Acute myocardial infarction | 156 | (16.0) | 167 | (4.9) | 23 | (16.2) | 14 | (3.2) |
| Mobility impairments | 105 | (10.7) | 111 | (3.2) | 23 | (16.2) | 32 | (7.4) |
aPer 10,000 USD; bConditions shown where frequency for all cells for individual conditions is ≥ 11 (Not shown: drug, alcohol and substance abuse, multiple sclerosis, spinal injury, hip fracture, autism spectrum disorder, bipolar disorder, hepatitis, HIV and schizophrenia)
Abbreviations: SD Standard Deviation, USD United States Dollars, IQR Interquartile range, COPD Chronic Obstructive Pulmonary Disease
Characteristics of respondents by race/ethnicity and potentially avoidable hospitalization status
| Non-Hispanic White ( | Non-Hispanic Black ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristics | Potentially avoidable Hospitalization ( | No Potentially avoidable Hospitalization ( | Potentially avoidable Hospitalization ( | No Potentially avoidable Hospitalization ( | |||||
| Age (years), mean (SD) | 81.1 | (8.00) | 79.7 | (7.32) | 78.9 | (7.62) | 78.3 | (7.5) | |
| Female, n (%) | 123 | (59.1) | 421 | (54.7) | 30 | (71.4) | 53 | (53.0) | |
| Wealth (USDa), median (IQR) | 18.5 | (5.6, 43.5) | 24.2 | (7.0, 63.0) | 0.8 | (0.0, 9.1) | 4.8 | (0.2, 14.3) | |
| Education (years), median (IQR) | 12.0 | (12.0, 14.0) | 12.0 | (12.0, 15.0) | 12.0 | (8.2, 12.0) | 12.0 | (10.0, 13.0) | |
| Chronic Conditions, n (%)b | |||||||||
| Hypertension | 202 | (97.1) | 733 | (95.2) | 42 | (100.0) | 99 | (99.0) | |
| Hyperlipidemia | 190 | (91.3) | 697 | (90.5) | 40 | (95.2) | 88 | (88.0) | |
| Anemia | 185 | (88.9) | 631 | (81.9) | 42 | (100.0) | 88 | (88.0) | |
| Ischemic heart disease | 167 | (80.3) | 589 | (76.5) | 37 | (88.1) | 82 | (82.0) | |
| Rheumatoid arthritis/osteoarthritis | 173 | (83.2) | 623 | (80.9) | 30 | (71.4) | 75 | (75.0) | |
| Heart failure | 157 | (75.5) | 400 | (51.9) | 36 | (85.7) | 62 | (62.0) | |
| Chronic kidney disease | 141 | (67.8) | 380 | (49.4) | 33 | (78.6) | 61 | (61.0) | |
| COPD | 141 | (67.8) | 317 | (41.2) | 28 | (66.7) | 42 | (42.0) | |
| Diabetes | 111 | (53.4) | 357 | (46.4) | 33 | (78.6) | 65 | (65.0) | |
| Depression | 115 | (55.3) | 388 | (50.4) | 20 | (47.6) | 38 | (38.0) | |
| Atrial fibrillation | 96 | (46.2) | 288 | (37.4) | 14 | (33.3) | 19 | (19.0) | |
| Alzheimer’s disease/senile dementia | 83 | (39.9) | 242 | (31.4) | 24 | (57.1) | 40 | (40.0) | |
| Acquired hypothyroidism | 87 | (41.8) | 272 | (35.3) | 18 | (42.9) | 26 | (26.0) | |
| Fibromyalgia/Chronic Pain/Fatigue | 76 | (36.5) | 318 | (41.3) | 20 | (47.6) | 26 | (26.0) | |
| Stroke/transient ischemic attack | 70 | (33.7) | 253 | (32.9) | 20 | (47.6) | 36 | (36.0) | |
| Obesity | 67 | (32.2) | 220 | (28.6) | 16 | (38.1) | 35 | (35.0) | |
| Asthma | 67 | (32.2) | 159 | (20.6) | 14 | (33.3) | 22 | (22.0) | |
aPer 10,000 USD; bConditions shown where frequency for all cells for individual conditions is ≥ 11. (Not shown: drug, alcohol and substance abuse, multiple sclerosis, spinal injury, hip fracture, autism spectrum disorder, bipolar disorder, hepatitis, HIV and schizophrenia)
Abbreviations: SD Standard Deviation, USD United States Dollars, IQR Interquartile range, COPD Chronic Obstructive Pulmonary Disease
Fig. 1Variable importance rankings of chronic conditions from conditional inference random forests for hospitalizations among 4,420 non-Hispanic White (left) and 573 non-Hispanic Black (right) Medicare beneficiaries
Results for hospitalizations by race for the top three chronic conditions from race-specific random forests
| Non-Hispanic White ( | Non-Hispanic Black ( | |||
|---|---|---|---|---|
| Chronic conditions | aOR* | (95% CI) | aOR* | (95% CI) |
| Chronic kidney disease | 2.41 | (2.06, 2.84) | 2.34 | (1.53, 3.61) |
| Heart failure | 2.39 | (2.02, 2.84) | - | |
| Atrial fibrillation | 1.99 | (1.67, 2.38) | - | |
| Acute MI | - | 3.39 | (1.60, 7.39) | |
| COPD | - | 2.79 | (1.81, 4.30) | |
*All models adjusted for age, sex, net worth, net worth squared, and education
Abbreviations: OR Odds Ratio, CI Confidence Interval, MI Myocardial Infarction, COPD Chronic Obstructive Pulmonary Disease
Fig. 2Variable importance rankings from Conditional Inference Random Forests for potentially avoidable hospitalizations among 978 non-Hispanic White (left) and 142 non-Hispanic Black (right) Medicare beneficiaries
Results for potentially avoidable hospitalizations by race for the top three chronic conditions from race-specific random forests
| Non-Hispanic White ( | Non-Hispanic Black ( | |||
|---|---|---|---|---|
| Chronic conditions | aOR* | (95% CI) | aOR* | (95% CI) |
| Asthma | 1.16 | (0.79, 1.69) | 1.08 | (0.42, 2.72) |
| COPD | 2.35 | (1.64, 3.39) | 2.84 | (1.24, 6.77) |
| Heart failure | 2.10 | (1.46, 3.06) | - | |
| Fibromyalgia/chronic pain/fatigue | - | 2.18 | (0.98, 4.90) | |
*All models adjusted for age, sex, net worth, net worth squared, and education
Abbreviations: OR Odds Ratio, CI Confidence Interval, COPD Chronic Obstructive Pulmonary Disease